ATLANTA -- Atlanta-based indoor air quality company Air Quality Sciences, Inc. (AQS), now offers a new analysis to test for Stachybotrys chartarum, often referred to as toxic mold, in a fungal sample. AQS is now proposing the use of Stachybotrys Selective Agar (SSA) to better detect the presence of this toxic mold in samples taken by building investigators.
SSA is specifically formulated to selectively recover Stachybotrys chartarum, using a combination of anti-fungal and antibiotic agents to prevent other fungi and bacteria from inhibiting the growth of Stachybotrys in the sample. Stachybotrys Selective Agar is designed to be used in combination with existing full characterization media such as MEA and DG-18, providing a complete picture of all fungi present in a sample. The addition of SSA to Air Quality Sciences' already extensive analytical capabilities enables building investigators to efficiently determine what mold species exist in a building.
SSA is ideal for experienced building investigators whose cases require full fungal species identification, such as high profile cases that may involve health concerns or litigation. The new agar is used in combination with existing laboratory agars to properly detect the presence of Stachybotrys chartarum, resulting in a comprehensive report for building investigators.
Stachybotrys Selective Agar can be used in conjunction with other agars to provide a building investigator with more complete information regarding the viable fungi of interest in a given environment. At AQS, all samples are expertly analyzed exclusively by degreed analysts and in accordance with AIHA EMLAP specifications.
Source: Air Quality Sciences, Inc.
Strengthening Defenses: Integrating Infection Control With Antimicrobial Stewardship
October 11th 2024Use this handout to explain the basics of why infection prevention and control and antimicrobial stewardship are essential and how the 2 fields must have a unified approach to patient and staff safety
Blood Product Overtransfusion Is a Global Issue: Here Are 5 Reasons the Practice Must Change
October 9th 2024If a patient receives treatment or therapy that they do not need, it can cause unnecessary harm. This is true for medications, surgeries, and medical procedures, especially blood transfusions.